ReviewDrug design, development and therapy2025

Current Perspectives on the NF-κB Signaling Axis as a Potential Pharmacological Target in Cardiorenal Syndrome.

Qian Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.